Search
for
Sort by
Research 121–150 of 1000+
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- Biologics in the management of childhood atopic dermatitis
- Two cases in which tofacitinib effectively treated both ulcerative colitis and alopecia areata
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- A New Framework for Understanding Hair‐Driven Medical Decisions
- A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
- Progress in Lipid and Inorganic Nanocarriers for Enhanced Skin Drug Delivery
- Medical Dermatology
- The microbiome in patients with atopic dermatitis
- JAK inhibitors in dermatology: The promise of a new drug class
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- TREM2 macrophages induced by human lipids drive inflammation in acne lesions
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Lipid Droplets from Plants and Microalgae: Characteristics, Extractions, and Applications
- Extracellular Vesicles for Regenerative Medicine Applications
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs